The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer

The gut microbiome (GM) plays an important role in shaping systemic immune responses and influences immune checkpoint inhibitor (ICI) efficacy. Antibiotics worsen clinical outcomes in patients receiving ICI. However, whether GM profiling and baseline antibiotic can be a biomarker of ICI efficacy in...

Full description

Saved in:
Bibliographic Details
Published inCancer immunology research Vol. 8; no. 10; p. 1243
Main Authors Hakozaki, Taiki, Richard, Corentin, Elkrief, Arielle, Hosomi, Yukio, Benlaïfaoui, Myriam, Mimpen, Iris, Terrisse, Safae, Derosa, Lisa, Zitvogel, Laurence, Routy, Bertrand, Okuma, Yusuke
Format Journal Article
LanguageEnglish
Published United States 01.10.2020
Online AccessGet more information

Cover

Be the first to leave a comment!
You must be logged in first